GenBank Accession No. NM 178423; Histone Deacetylase 9
For active pharmaceutical ingredients (APIs) related to HDAC9 (human recombinant), see Cayman Pharma
![]() |
![]() |
![]() |
![]() |
|
Source:
human recombinant protein consisting of amino acids 604- |
|
1
Lin, H., Chen, C., Lin, S., et al. Targeting histone deacetylase in cancer therapy. Med Res Rev 26(4) 397-
2
Huang, L. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases. J Cell Physiol 39.1, 611-
|
![]() | Download Product Insert 77 Kb PDF |
![]() | Download Material Safety Data Sheet (MSDS) 22 Kb PDF |
Prices listed here are the Manufacturer's Suggested European Retail Price. The actual prices quoted by each individual distributor may vary. Please visit the Global Buyer's Guide on the Cayman Chemical (world) website to locate a distributor in your region.
This product is also available to buy in bulk quantities. Please contact us for a quote or to purchase.
Cayman strives to be a reliable biochemical reagent vendor by providing the best possible products and services. To ask for assistance with one of our products please contact our Technical Help staff.
Warning This product is not for human or veterinary use.
|
Item total €0.00
Shopping cart total €0.00 |
| Tel | 372 670 32 32 |
|---|---|
| 372 670 37 37 | |
| Fax | 372 670 36 83 |
![]() |
| Search for products using a keyword, CAS number, or Cayman catalog number. |
| Other resources |
|
· MSDSs
|
|
|
|
|
|
|
|
|






